HOUSTON AMERICAN ENERGY CORP (HUSA)

US44183U2096 - Common Stock

1.24  +0.02 (+1.64%)

After market: 1.2398 0 (-0.02%)

Fundamental Rating

2

Taking everything into account, HUSA scores 2 out of 10 in our fundamental rating. HUSA was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. While HUSA has a great health rating, there are worries on its profitability. HUSA does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

In the past year HUSA has reported negative net income.
In the past year HUSA had a positive cash flow from operations.
In the past 5 years HUSA always reported negative net income.
In the past 5 years HUSA reported 4 times negative operating cash flow.

1.2 Ratios

HUSA's Return On Assets of -31.75% is on the low side compared to the rest of the industry. HUSA is outperformed by 97.14% of its industry peers.
HUSA has a Return On Equity of -33.21%. This is amonst the worse of the industry: HUSA underperforms 89.05% of its industry peers.
Industry RankSector Rank
ROA -31.75%
ROE -33.21%
ROIC N/A
ROA(3y)-15.71%
ROA(5y)-29.69%
ROE(3y)-16.31%
ROE(5y)-32.47%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 26.26%, HUSA is doing worse than 64.29% of the companies in the same industry.
In the last couple of years the Gross Margin of HUSA has declined.
The Profit Margin and Operating Margin are not available for HUSA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.91%
GM growth 5Y-7.96%

8

2. Health

2.1 Basic Checks

HUSA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HUSA has been increased compared to 1 year ago.
The number of shares outstanding for HUSA has been increased compared to 5 years ago.
There is no outstanding debt for HUSA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

HUSA has an Altman-Z score of 6.95. This indicates that HUSA is financially healthy and has little risk of bankruptcy at the moment.
HUSA has a better Altman-Z score (6.95) than 90.48% of its industry peers.
There is no outstanding debt for HUSA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.95
ROIC/WACCN/A
WACC8.91%

2.3 Liquidity

A Current Ratio of 11.27 indicates that HUSA has no problem at all paying its short term obligations.
The Current ratio of HUSA (11.27) is better than 94.29% of its industry peers.
A Quick Ratio of 11.27 indicates that HUSA has no problem at all paying its short term obligations.
The Quick ratio of HUSA (11.27) is better than 94.76% of its industry peers.
Industry RankSector Rank
Current Ratio 11.27
Quick Ratio 11.27

0

3. Growth

3.1 Past

The earnings per share for HUSA have decreased strongly by -515.86% in the last year.
The Revenue for HUSA has decreased by -50.88% in the past year. This is quite bad
Measured over the past years, HUSA shows a very negative growth in Revenue. The Revenue has been decreasing by -19.58% on average per year.
EPS 1Y (TTM)-515.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-114.4%
Revenue 1Y (TTM)-50.88%
Revenue growth 3Y13.02%
Revenue growth 5Y-19.58%
Sales Q2Q%-35.79%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

HUSA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of HUSA indicates a slightly more expensive valuation: HUSA is more expensive than 60.95% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 36.97
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HUSA!.
Industry RankSector Rank
Dividend Yield N/A

HOUSTON AMERICAN ENERGY CORP

NYSEARCA:HUSA (7/26/2024, 7:04:00 PM)

After market: 1.2398 0 (-0.02%)

1.24

+0.02 (+1.64%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap13.53M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.75%
ROE -33.21%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 26.26%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 11.27
Quick Ratio 11.27
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-515.86%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-50.88%
Revenue growth 3Y13.02%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y